Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer.
- Resource Type
- Article
- Source
- Bioengineered; Jan2022, Vol. 13 Issue 1, p128-139, 12p
- Subject
- Language
- ISSN
- 21655979